Collaborating with hospitals and industry in cell therapies


Cate Dyer, CEO & Founder, StemExpress, Folsom, CA, gives an overview of ongoing work by StemExpress in supporting the cell therapy manufacturers in terms of research & development, clinical trials and eventual commercialization. Isolation and collection of cells are a critical part in the production of cell therapies and StemExpress assists in the process, focusing on the logistics of delivering product to and from patients. This interview took place at Advanced Therapies Week 2022.


Leave A Reply

Your email address will not be published.